WebShares Outstanding: Common shares outstanding as reported by the company on the 10-Q or 10-K. Annual Sales: The annual sales, expressed in millions of dollars. Annual Income: … WebCompany profile page for Pernix Therapeutics Holdings Inc including stock price, company news, press releases, executives, board members, and contact information
Pernix Therapeutics : Closes on Sale of Manufacturing Facility
http://filings.irdirect.net/data/1024126/000135448814001218/ptx_10k.pdf WebDec 10, 2012 · I and Somaxon Pharmaceuticals, Inc from PERNIX THERAPEUTICS HOLDINGS, INC. filed with the Securities and Exchange Commission. Log In Sign Up. Find a Lawyer; Ask a Lawyer ; Research the Law; Law Schools ... 2011 included in the Company’s annual report filed on Form 10-K for the year ended December 31, 2011, including the … drug cross checker
Pernix Therapeutics Holdings, Inc. (PTX) 10-Q Quarterly Report …
WebBe Biopharma is a leader in developing B cells as medicines, treating disease with the human body’s native protein factories. We precisely engineer B cells to harness their … WebPERNIX Therapeutics, LLC October 1, 2013 THIS AGREEMENT, by and between Cumberland Pharmaceuticals Inc., a Tennessee corporation (“CUMBERLAND”), and Pernix Therapeutics, LLC, a Louisiana limited liability company (“PERNIX”) is effective as of October 1, 2013 (the “Effective Date”). RECITALS WebMar 4, 2024 · Pernix Therapeutics is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The company’s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper ... comb binding hole punch